Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Caffeine for Apnea of Prematurity (CAP)
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants
Status: Enrolling
Updated:  3/20/2018
mi
from
Brooklyn, NY
Caffeine for Apnea of Prematurity (CAP)
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants
Status: Enrolling
Updated: 3/20/2018
Brooklyn Hospital Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
ADDRESS - Multicenter, Partially-randomized Controlled Trial of Adult Deformity Robotic vs. Freehand Surgery to Correct Adult Spine Deformity
Status: Enrolling
Updated:  3/21/2018
mi
from
Kansas City, KA
ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity
ADDRESS - Multicenter, Partially-randomized Controlled Trial of Adult Deformity Robotic vs. Freehand Surgery to Correct Adult Spine Deformity
Status: Enrolling
Updated: 3/21/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated:  3/22/2018
mi
from
New York, NY
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated:  3/22/2018
mi
from
Calgary,
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Status: Enrolling
Updated: 3/22/2018
Tom Baker Cancer Centre
mi
from
Calgary,
Click here to add this to my saved trials
Surface Stimulation for Female Sexual Dysfunction
Surface Stimulation for Female Sexual Dysfunction
Status: Enrolling
Updated:  3/22/2018
mi
from
Ann Arbor, MI
Surface Stimulation for Female Sexual Dysfunction
Surface Stimulation for Female Sexual Dysfunction
Status: Enrolling
Updated: 3/22/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents
Status: Enrolling
Updated:  3/23/2018
mi
from
Columbus, OH
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
Relationship Between Drug Exposure and DNA Markers With Depot Medroxyprogesterone Acetate-associated Side Effects in Adolescents
Status: Enrolling
Updated: 3/23/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Timing of Pessary Care
Timing of Pessary Care
Status: Enrolling
Updated:  3/23/2018
mi
from
Hartford, CT
Timing of Pessary Care
Timing of Pessary Care
Status: Enrolling
Updated: 3/23/2018
Hartford Hospital, Urogynecology Division
mi
from
Hartford, CT
Click here to add this to my saved trials
Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
A Multicenter, 6-week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of NFC-1 in Adolescents (Ages 12-17) With Genetic Disorders Impacting Metabotropic Glutamate Receptors and ADHD
Status: Enrolling
Updated:  3/27/2018
mi
from
Baltimore, MD
Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD
A Multicenter, 6-week, Double-blind, Randomized, Placebo-controlled, Parallel-design Study to Assess the Efficacy and Safety of NFC-1 in Adolescents (Ages 12-17) With Genetic Disorders Impacting Metabotropic Glutamate Receptors and ADHD
Status: Enrolling
Updated: 3/27/2018
The Clinical Trials Center at Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Randomized, Prospective Trial Comparing the Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Status: Enrolling
Updated:  3/27/2018
mi
from
Washington,
Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Randomized, Prospective Trial Comparing the Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
Status: Enrolling
Updated: 3/27/2018
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
HLA-mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High Risk Acute Myeloid Leukemia
Status: Enrolling
Updated:  3/28/2018
mi
from
Los Angeles, CA
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
HLA-mismatched Allogeneic Cellular Therapy (HMMACT) After Chemotherapy in High Risk Acute Myeloid Leukemia
Status: Enrolling
Updated: 3/28/2018
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Group vs. Traditional Diabetes Prenatal Care
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
Status: Enrolling
Updated:  3/28/2018
mi
from
Madison, WI
Group vs. Traditional Diabetes Prenatal Care
Group Prenatal Care Compared to Traditional Prenatal Care for Women With Pre-gestational Diabetes: A Randomized Clinical Trial.
Status: Enrolling
Updated: 3/28/2018
UnityPoint Health-Meriter Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study
Insulin and the Polycystic Ovary Syndrome
Status: Enrolling
Updated:  3/29/2018
mi
from
Richmond, VA
Insulin and the Polycystic Ovary Syndrome--Weight Reduction Study
Insulin and the Polycystic Ovary Syndrome
Status: Enrolling
Updated: 3/29/2018
Virginia Commonwealth University General Clinical Research Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Veress Entry With/Without Concomitant CO2
Laparoscopic Entry Technique With a Veress Needle Insertion With and Without Concomitant CO2 Insufflation - Does it Matter?
Status: Enrolling
Updated:  3/29/2018
mi
from
Tampa, FL
Veress Entry With/Without Concomitant CO2
Laparoscopic Entry Technique With a Veress Needle Insertion With and Without Concomitant CO2 Insufflation - Does it Matter?
Status: Enrolling
Updated: 3/29/2018
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Status: Enrolling
Updated:  3/30/2018
mi
from
Bronx, NY
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Status: Enrolling
Updated: 3/30/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia
Status: Enrolling
Updated:  4/3/2018
mi
from
New York, NY
Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
Comparison of Fentanyl-bupivacaine and Clonidine-bupivacaine for Breakthrough Pain in Advanced Labor in Patients With Continuous Epidural Analgesia
Status: Enrolling
Updated: 4/3/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated:  4/3/2018
mi
from
Los Angeles, CA
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated: 4/3/2018
Beverly Hills Sunset Surgery Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated:  4/3/2018
mi
from
Atlanta, GA
Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair
Laparoscopic 3D Versus 2D Sacral Colpopexy and Paravaginal Repair for Pelvic Organ Prolapse: a Comparison of Operative Times and Complications
Status: Enrolling
Updated: 4/3/2018
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
ToRsemide for pOstpartum HYpertension
Torsemide for the Prevention of Persistent Postpartum Hypertension in Preeclamptic Women: A Randomized, Placebo-Control Trial
Status: Enrolling
Updated:  4/3/2018
mi
from
Houston, TX
ToRsemide for pOstpartum HYpertension
Torsemide for the Prevention of Persistent Postpartum Hypertension in Preeclamptic Women: A Randomized, Placebo-Control Trial
Status: Enrolling
Updated: 4/3/2018
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Studies of Heritable Disorders of Connective Tissue
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
Status: Enrolling
Updated:  4/4/2018
mi
from
Baltimore, MD
Studies of Heritable Disorders of Connective Tissue
Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue
Status: Enrolling
Updated: 4/4/2018
National Institute of Aging, Clinical Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Global Study of Women's Health
Global Study of Women's Health
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Global Study of Women's Health
Global Study of Women's Health
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated:  4/4/2018
mi
from
Chicago, IL
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated:  4/4/2018
mi
from
Baltimore, MD
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated:  4/4/2018
mi
from
Houston, TX
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia
A Phase 2 Study of MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Acute Myeloid Leukemia (AML) With RAS Mutations
Status: Enrolling
Updated: 4/4/2018
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oxytocin Trial in Prader-Willi Syndrome
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated:  4/4/2018
mi
from
Orange, CA
Oxytocin Trial in Prader-Willi Syndrome
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Oxytocin Trial in Prader-Willi Syndrome
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated:  4/4/2018
mi
from
Gainesville, FL
Oxytocin Trial in Prader-Willi Syndrome
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oxytocin Trial in Prader-Willi Syndrome
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated:  4/4/2018
mi
from
Kansas City, KA
Oxytocin Trial in Prader-Willi Syndrome
Oxytocin Trial in Prader-Willi Syndrome
Status: Enrolling
Updated: 4/4/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated:  4/4/2018
mi
from
Detroit, MI
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated: 4/4/2018
Harper University Hospital Department of Infectious Diseases
mi
from
Detroit, MI
Click here to add this to my saved trials
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated:  4/4/2018
mi
from
Philadelphia, PA
LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study
An Open-Label, Randomized Study to Determine the Safety and Efficacy of LUXSOL(TM) Cream for the Treatment of Bacterial Vaginosis: A Proof of Concept Study
Status: Enrolling
Updated: 4/4/2018
Temple University Hospital Department of OB/GYN
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Human Sperm Binding to Transgenic Mouse Eggs
Human Sperm Binding to Transgenic Mouse Eggs
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Human Sperm Binding to Transgenic Mouse Eggs
Human Sperm Binding to Transgenic Mouse Eggs
Status: Enrolling
Updated: 4/4/2018
Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta
HPV Testing to Improve Cervical Cancer Screening in the Mississippi Delta (Mississippi Delta Project)
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta
HPV Testing to Improve Cervical Cancer Screening in the Mississippi Delta (Mississippi Delta Project)
Status: Enrolling
Updated: 4/4/2018
National Cancer Institute , 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated:  4/4/2018
mi
from
Bethesda, MD
Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine
Thyroid Abnormalities Associated With Protracted Childhood I-131 Exposure From Atmospheric Emissions From the Mayak Nuclear Plant in Russia
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Montgomery, AL
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Drug Research & Analysis Corporation
mi
from
Montgomery, AL
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Tucson, AZ
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Tucson Medical Center (Watching Over Mothers and Babies Foundation)
mi
from
Tucson, AZ
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
La Mesa, CA
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Grossmont Center for Clinical Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
San Diego, CA
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Naval Medical Center San Diego - Department of Obstetrics and Gynecology
mi
from
San Diego, CA
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
West Hills, CA
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Womens Health Specialists
mi
from
West Hills, CA
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Colorado Springs, CO
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Women's Associates, P.C.
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Lakewood, CO
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Red Rocks OB/GYN - Physician's Research Options, LLC
mi
from
Lakewood, CO
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Boynton Beach, FL
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Visions Clinical Research
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Lake Worth, FL
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Palm Beach Obstetrics & Gynecology, PA (Altus Research)
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Pembroke Pines, FL
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Global Ob/Gyn Centers
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Riverdale, GA
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
New Millennium Obstetrics & Gynecology, LLc
mi
from
Riverdale, GA
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Honolulu, HI
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Tripler Army Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Boise, ID
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Women's Clinic
mi
from
Boise, ID
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Idaho Falls, ID
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Rosemark Women Care Specialists
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Louisville, KY
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Louisville, KY
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Women's Care Physicians/Obstetrical Specialists, PLLC
mi
from
Louisville, KY
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Bel Air, MD
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Steven Z. Lenowitz, MD, LLC
mi
from
Bel Air, MD
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Grand Rapids, MI
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Female Pelvic Medicine & Urogynecology Institute of Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated:  4/5/2018
mi
from
Saginaw, MI
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
A Phase 3B, Multi-Center, Randomized, Double-Blind Study of Hydroxyprogesterone Caproate Injection, 250 mg/mL, Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 4/5/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
Click here to add this to my saved trials